SignalChem Lifesciences (SLC) is committed to improving the care and outcome of patients by creating drugs to address unmet medical needs and that complement or replace existing treatments.
- SignalChem Appoints Darren Z. Ready as Chief Financial Officer
- SignalChem Lifesciences Appoints New Chief Business Officer
- Carbonic Anhydrase 9 (CAIX) and its Implications in Cancer
- Overcoming Cancer – The Critical Role of CAIX
- SignalChem Lifesciences Director Dr. Claudiu T. Supuran is the Most Cited Author for Research related to Pharmacology and Pharmacy